ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
97,122.87
2.93%
S&P 500
5,917.72
0.01%
Dow Jones
43,502.23
0.22%
US Dollar vs Yen
154.0775
-0.78%
Brent Oil
73.695
1.17%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. イギリス
  5. LSE
  6. Hemogenyx Pharmaceuticals Plc (HEMO)

  7. Hemogenyx Pharmaceuticals Plc (HEMO) ニュース

HEMO

Hemogenyx Pharmaceuticals (HEMO)

Hemogenyx Pharmaceuticals Plc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:LSE:HEMO
日付受信時刻ニュースソース見出しコード企業名
2024/11/1116 : 00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Institutional InvestmentLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/10/3020 : 09Alliance NewsAlliance NewsIN BRIEF: Hemogenyx to launch myeloid leukemia treatment phase 1 trialLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/10/3016 : 00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Schedule for Phase I Clinical Trial OpeningLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/10/0219 : 19RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Strategic Investment from Prevail Partners, LLCLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/09/2802 : 25Alliance NewsAlliance NewsHemogenyx Pharmaceuticals loss narrows amid reduced expensesLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/09/2723 : 55Alliance NewsAlliance NewsEARNINGS: Clean Power Hydrogen loss widens; Invinity loss narrowsLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/09/2715 : 00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Half-year ReportLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/09/1006 : 03Alliance NewsAlliance NewsTRADING UPDATES: Light Science Technologies wins two new contractsLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/09/0915 : 00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC FLT3 Assay Ready for Phase I Trials at MD AndersonLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/09/0215 : 00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC CDX Development UpdateLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/08/2815 : 00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Presentation at CBD S&T ConferenceLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/07/2915 : 00RNS Non-RegulatoryHemogenyx Pharmaceuticals PLC Macrophage-Directed Therapies Summit PresentationLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/06/2800 : 39RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Result of Annual General MeetingLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/06/1803 : 55Alliance NewsAlliance NewsIN BRIEF: Hemogenyx Pharmaceuticals updates on leukemia treatmentLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/06/1715 : 00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Operations UpdateLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/06/0315 : 00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Posting of Annual Report & Notice of AGMLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/04/2520 : 19Alliance NewsAlliance NewsEARNINGS: LSL starts 2024 "strongly"; Focusrite maintains payoutLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/04/2515 : 00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Final ResultsLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/03/2816 : 00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Total Voting RightsLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/2923 : 04Alliance NewsAlliance NewsHemogenyx Pharmaceuticals raises money for leukaemia treatmentLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/2916 : 00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Placing to Raise US$4.2 millionLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/1620 : 27Alliance NewsAlliance NewsHemogenyx shares rise on potential for CBR to treat brain diseasesLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/1616 : 00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC CBR Brain DeliveryLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/1419 : 14Alliance NewsAlliance NewsHemogenyx says CBR can be used intranasally to treat viral infectionsLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/1416 : 00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC CBR Intranasal DeliveryLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/0919 : 00Alliance NewsAlliance NewsIN BRIEF: Hemogenyx shares surge as FDA lifts Hemo-Car-T trial holdLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/0916 : 00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC FDA Consents to Phase I Trials of HEMO-CAR-TLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/0219 : 44Alliance NewsAlliance NewsIN BRIEF: Hemogenyx hails US patent application progressLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/0216 : 00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Approval and Issuance of U.S. Conditioning PatentLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/01/1620 : 13Alliance NewsAlliance NewsHemogenyx Pharmaceuticals sends complete response on HEMO-CAR-T to FDALSE:HEMOHemogenyx Pharmaceuticals Plc
 Showing the most relevant articles for your search:LSE:HEMO

最近閲覧した銘柄

NYSE
BAC
Bank of America
USOTC
ADDYY
Adidas (QX)
CCOM
US500
US 500
NASDAQ
NVDA
NVIDIA
SPI
SP500
S&P 500
NYSE
MCD
McDonalds
NYSE
CVX
Chevron
NASDAQ
MSFT
Microsoft
AMEX
XLV
Health Care Select Sector
NASDAQ
GOOGL
Alphabet
COIN
XRPUSD
Ripple
NASDAQ
QQQ
Invesco QQQ Trust Series 1
COIN
DOGEUSD
Dogecoin
FX
USDEUR
US Dollar vs Euro
USOTC
DTEGY
Deutsche Telekom (QX)
USOTC
RHHBY
Roche (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有